Role of NLRP3 Inflammasome in post-spinal-cord-injury anxiety and depression: molecular mechanisms and therapeutic implications
T Mokhtari, K Uludag - ACS Chemical Neuroscience, 2023 - ACS Publications
The majority of research on the long-term effects of spinal cord injury (SCI) has primarily
focused on neuropathic pain (NP), psychological issues, and sensorimotor impairments …
focused on neuropathic pain (NP), psychological issues, and sensorimotor impairments …
Modulating the immune system as a therapeutic target for myelodysplastic syndromes and acute myeloid leukemia
CM Putnam, L Kondeti, MBA Kesler… - Biochemistry and Cell …, 2023 - cdnsciencepub.com
Modulating the immune system to treat diseases, including myeloid malignancies, has
resulted in the development of a multitude of novel therapeutics in recent years …
resulted in the development of a multitude of novel therapeutics in recent years …
New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation
Inflammasomes are important modulators of inflammation. Dysregulation of inflammasomes
can enhance vulnerability to conditions such as neurodegenerative diseases …
can enhance vulnerability to conditions such as neurodegenerative diseases …
Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression
Q Han, W Li, P Chen, L Wang, X Bao… - Neural Regeneration …, 2024 - journals.lww.com
Previous studies have demonstrated a bidirectional relationship between inflammation and
depression. Activation of the nucleotide-binding oligomerization domain, leucine-rich repeat …
depression. Activation of the nucleotide-binding oligomerization domain, leucine-rich repeat …
Can pyroptosis be a new target in rheumatoid arthritis treatment?
D Wu, Y Li, R Xu - Frontiers in Immunology, 2023 - frontiersin.org
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease of undefined etiology,
with persistent synovial inflammation and destruction of articular cartilage and bone. Current …
with persistent synovial inflammation and destruction of articular cartilage and bone. Current …
A review of studies on the implication of NLRP3 inflammasome for Parkinson's disease and related candidate treatment targets
N Zeng, Q Wang, C Zhang, Y Zhou, J Yan - Neurochemistry International, 2023 - Elsevier
Parkinson's disease (PD) is a neurodegenerative disease for which the prevalence is
second only to Alzheimer's disease (AD). This disease primarily affects people of middle and …
second only to Alzheimer's disease (AD). This disease primarily affects people of middle and …
Resveratrol attenuates chronic social isolation stress‐induced affective disorders: Involvement of NF‐κB/NLRP3 axis
M Zarebavani, F Baghaei Naeini… - … of Biochemical and …, 2023 - Wiley Online Library
Social isolation stress (SIS) is associated with affective disorders (ie, anxiety and
depression) in adults. In a preclinical study, we aimed to investigate the effects of resveratrol …
depression) in adults. In a preclinical study, we aimed to investigate the effects of resveratrol …
NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
P Chen, X Li - Frontiers in Pharmacology, 2024 - frontiersin.org
Atherosclerosis (AS) is the primary pathology behind various cardiovascular diseases and
the leading cause of death and disability globally. Recent evidence suggests that AS is a …
the leading cause of death and disability globally. Recent evidence suggests that AS is a …
Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases
ZE Fang, Y Wang, S Bian, S Qin, H Zhao, J Wen, T Liu… - Phytomedicine, 2024 - Elsevier
Background The involvement of NLRP3 inflammasome is associated with the progress of
numerous inflammatory conditions. However, there is currently no single compound used in …
numerous inflammatory conditions. However, there is currently no single compound used in …
NLRP3 Inflammasome Inhibitors for Antiepileptogenic Drug Discovery and Development
Epilepsy is one of the most prevalent and serious brain disorders and affects over 70 million
people globally. Antiseizure medications (ASMs) relieve symptoms and prevent the …
people globally. Antiseizure medications (ASMs) relieve symptoms and prevent the …